Abstract:Alkali burn is one of the main causes of corneal injury. The inflammation and neovascularization caused by alkali burns aggravate corneal damage, resulting in loss of vision. The aim of the present study was to evaluate the efficacy of xanthatin in the treatment of alkali burn-induced inflammation and neovascularization. A CCK-8 assay was used to detect the effects of different concentrations of xanthatin on the proliferation of human umbilical vein endothelial cells (HUVECs). The effects of xanthatin on the migration of HUVECs and the ability of lumen formation were examined using a scratch test and lumen formation assay, respectively. A total of 60 Sprague-Dawley rats were randomly divided into two groups to establish a corneal alkali burn model, and were treated with PBS and xanthatin eye drops four times a day. A slit lamp microscope recorded changes of the cornea at 0, 4, 7, 10 and 14 days, and the inflammatory indices of the cornea and the neovascular area were evaluated. The expression levels of vascular endothelial growth factor (VEGF) and pigment epithelium-derived factor (PEDF) in the cornea under different treatment conditions were detected using immunofluorescence and western blot analysis. In order to investigate the mechanism of xanthatin on the inhibition of inflammation and neovascularization, HUVECs were treated with xanthatin and PBS following VEGF treatment. The subcellular localization of signal transducer and activator of transcription 3 (STAT3) was detected using immunofluorescence. The expression levels of VEGF receptor 2 (VEGFR2), STAT3, phosphoinositide 3-kinase (PI3K) and Akt were detected using western blot analysis. The results revealed that xanthatin inhibited the proliferation of HUVECs in a concentration-dependent manner. The migration ability and lumen-forming ability of the HUVECs were also inhibited by xanthatin. Slit lamp microscopy showed that the inflammatory index and the area of neovascularization in the xanthatin-treated group were significantly reduced, compared with those in the PBS treatment group. The xanthatin treatment group exhibited a lower protein expression level of VEGF and increased protein expression level of PEDF, compared with the PBS treatment group. In the VEGF-treated HUVECs, xanthatin significantly decreased the expression levels of p-VEGFR2, phosphorylated (p-)STAT3, p-PI3K and p-Akt. In conclusion, the present study confirmed that xanthatin inhibited corneal neovascularization and inflammation in the alkali burn model, elucidating the underlying mechanisms involved in its protective effects. Therefore, xanthatin may be a novel drug for the treatment of corneal alkali burn.

Upadacitinib Inhibits Corneal Inflammation and Neovascularization by Suppressing M1 Macrophage Infiltration in the Corneal Alkali Burn Model.

Neutrophil extracellular traps promote corneal neovascularization-induced by alkali burn

Acetylsalicylic Acid Promotes Corneal Epithelium Migration by Regulating Neutrophil Extracellular Traps in Alkali Burn

Histone Methylation Regulates Neutrophil Extracellular Traps to Attenuate Corneal Neovascularization

Daphnetin inhibits corneal inflammation and neovascularization on a mouse model of corneal alkali burn

Efficacy Of The Nucleotide-Binding Oligomerization Domain 1 Inhibitor Nodinhibit-1 On Corneal Alkali Burns In Rats

Effects Of Amd3100 Subconjunctival Injection On Alkali Burn Induced Corneal Neovascularization In Mice

Inhibitory Effect Of Ccr3 Signal On Alkali-Induced Corneal Neovascularization

The Effect of TC14012 on Alkali Burn-Induced Corneal Neovascularization in Mice

Minocycline Inhibits Alkali Burn-Induced Corneal Neovascularization In Mice

The Long-Term Effect of Tacrolimus on Alkali Burn-Induced Corneal Neovascularization and Inflammation Surpasses That of Anti-Vascular Endothelial Growth Factor

Pharmacological Inhibition of Glutaminase 1 Attenuates Alkali-Induced Corneal Neovascularization by Modulating Macrophages

Topical Administration of 0.3% Tofacitinib Suppresses M1 Macrophage Polarization and Allograft Corneal Rejection by Blocking STAT1 Activation in the Rat Cornea

Emodin Suppresses Alkali Burn-Induced Corneal Inflammation and Neovascularization by the Vascular Endothelial Growth Factor Receptor 2 Signaling Pathway.

Xanthatin Inhibits Corneal Neovascularization by Inhibiting the VEGFR2‑mediated STAT3/PI3K/Akt Signaling Pathway.

Drp1-dependent mitochondrial fission mediates corneal injury induced by alkali burn

Targeting HMGB1-NFκb Axis and miR-21 by Glycyrrhizin: Role in Amelioration of Corneal Injury in a Mouse Model of Alkali Burn

Forkhead Domain Inhibitor-6 Suppresses Corneal Neovascularization and Subsequent Fibrosis After Alkali Burn in Rats

Netrin-1 Simultaneously Suppresses Corneal Inflammation And Neovascularization

MK2 inhibitor reduces alkali burn-induced inflammation in rat cornea

Effect of exogenous TNF-α on corneal neovascularization induced by alkali burn